Canaccord Genuity Slashes PT on Enovis Corporation (ENOV) to $50 From $58

1 week ago 7

Noor Ul Ain Rehman

Sun, December 21, 2025 astatine 8:57 AM CST 2 min read

Enovis Corporation (NYSE:ENOV) is 1 of the champion small headdress stocks to bargain with immense upside potential. Canaccord Genuity slashed the terms people connected Enovis Corporation (NYSE:ENOV) to $50 from $58 connected December 17 and maintained a Buy standing connected the stock. The steadfast updated its exemplary connected the institution to instrumentality into relationship its caller 2027 estimates, with immoderate updates to its 2026 estimates arsenic well.

In addition, Enovis Corporation (NYSE:ENOV) was initiated with a Buy standing by Freedom Capital expert Keith Hinton connected December 16, who acceptable a $45 terms people connected the stock. The expert told investors that the orthopedics-focused medtech institution is undergoing a rebound successful integrated maturation successful 2025, and the momentum is expected to continue.

He views the company’s improving competitory positioning to beryllium “underappreciated”, with shares trading adjacent their post-spin lows and reducing M&A dyssynergies diminishing. Hinton anticipates the aggregate to statesman bridging the spread with peers, provided the caller CEO continues execution.

Separately, successful its fiscal Q3 2025 results, Enovis Corporation (NYSE:ENOV) reported that its nett income for the 4th roseate 9% connected a reported ground and 7% connected an integrated ground to $549 cardinal compared to the aforesaid 4th past year, with the quarterly results reflecting unchangeable extremity markets, encouraging momentum successful caller merchandise introductions, and continued execution successful P&R and Recon. Net income successful Recon roseate 2% connected a reported ground and 9% connected an integrated ground compared to the anterior twelvemonth period, and P&R grew 6% connected a reported ground and 4% connected an integrated basis.

Enovis Corporation (NYSE:ENOV) is simply a aesculapian exertion maturation institution that develops clinically differentiated solutions to alteration workflows and make amended diligent outcomes. The institution operates done the Prevention & Recovery and Reconstructive segments.

While we admit the imaginable of XXXX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.